← Back to headlines
H.C. Wainwright Bullish on Halozyme Therapeutics Commercial Revenue Outlook
H.C. Wainwright has expressed a bullish sentiment regarding Halozyme Therapeutics, Inc. (HALO), particularly concerning its commercial revenue outlook.
11 May, 20:05 — 11 May, 20:05
Sources
Showing 1 of 1 sources
